More information: Jacqueline Fátima Martins de Almeida et al, Molecular aspects of Angelman Syndrome: Defining the new path forward, Biomolecules and Biomedicine (2025). DOI: 10.17305/bb.2025.11724 ...

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) is one of the 10 best healthcare penny stocks to buy according to analysts. On June ...

The five-year-old also has Angelman syndrome – a neurogenetic disorder affecting about 1 in 15,000 people and approximately 500,000 worldwide. People living with Angelman syndrome have a genetic ...

Prader-Willi syndrome is a study in contrast — children who once couldn’t eat later battle an urge to never stop. The ...

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds. The initial ...

CARLSBAD, Calif., June 11, 2025--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the first participant has been dosed in the global Phase 3 REVEAL study, which is designed to ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the first participant has been dosed in the global Phase 3 REVEAL study, which is designed to evaluate the efficacy and safety of ...

A study from the USC Leonard Davis School of Gerontology reveals a significant relationship between elevated iron levels in the brain and greater cellular damage in individuals with both Down syndrome ...

More information: Benjamin J Buehner et al, Medial temporal lobe atrophy in Down syndrome along the Alzheimer's disease continuum, Brain (2025). DOI: 10.1093/brain/awaf133 ...